Health Discovery Corp (HDVY)

[king oil]

So now the big question is if this test will generate any meaningful revenue for HDVY, and for how long before another test is developed?

Plasma Test for Prostate Cancer

NeoGenomics is developing a Blood Test for Prostate Cancer under the direction of Dr. Maher Albitar using the genes patented by HDC. The test is performed on blood plasma and urine rather than only prostate tissue biopsies. NeoGenomics completed Phase I of their research and published the results in 2014. Additionally, NeoGenomics completed Phase II of their prostate test validation in 2014. The results were largely the same as those published regarding Phase I. NeoGenomics is currently concluding a clinical trial for this test, named NeoLAB™ Prostate – Liquid Alternative to Biopsy. NeoGenomics announced in March 2016 the test is now commercially available.